• Mon news: AZ obesity pill. 50% of drug shortages last at least 2 years. Pharmas and IRA lawsuit appeals. Novo-Ascendis biobucks deal. Wegovy reduces all-cause hospital admissions. See more on our front page

SlowTykToo down 18%!!!! in Quarter 3 Earnings Report!!!!!

Quote






Not even prioritized and barely discussed during earnings call. And no questions from the audience. Keep believing that adding people to the sales team is the savior. You are a widget in the machine & the machine is about to spit this mess out. Doomed
 




Sales were down because the same period last year we had a $40million "clinical buy" added in to make our numbers look better. If you actually look at sales we are growing about 1.2% YOY. LFG!

Biggest flop in Pharma history?
 




Prepare for the elimination of the entire dermatology division. If you haven't started heading for the exits you are a fool. This house of Sotyktu cards is tumbling down at any moment.
 








anonymous said:
Love,
Amgen
Click to expand...
You are so full of shit. Amgen doesn't care. Their derm reps are the worst around now. They mail it in and don't attend lunches or local conferences anymore. Reminds me of the Enbrel reps when they vanished.

The taunting posts are likely from JNJ or Abbvie. Maybe even ARQT or Dermavant reps but certainly not the wokesters in Thousand Oaks.

Find a crybaby response.
 












anonymous said:
By all means, just ignore the earnings report and cry like a pussy about Amgen.

Fact is, we are soon starting year three and we sell $50 million a quarter. Nuff said.
Click to expand...
Stick with the facts. Amgen's earnings call was horrific had massive cuts in Derm this week. The Rheum group was cut by 60%. De-vesting in Otezla.
 




anonymous said:
Stick with the facts. Amgen's earnings call was horrific had massive cuts in Derm this week. The Rheum group was cut by 60%. De-vesting in Otezla.
Click to expand...
Dude - know you're desperate but facts are that Amgen cut rheumatology and neurology. They didn't cut derm. In fact they added KOL Liaison reps. Stock was up yesterday after earnings. Down on some profit taking today. Look at the 5 or 10 year returns and compare to us.

They aren't divesting Otezla (no idea meat head what "de-vesting" means). They are likely to divert their OX40. It's not as efficacious as advertised and it's 3 years late.

Now drink an energy drink or do something to wake your sleep ass up. You make yourself look bad.
 








anonymous said:
The ELT that sold Otezla to Amgen only to get Sojaktoo should all be fired. Every last one. WORST DEAL IN PHRMA HISTORY!!! That revenue would come in handy.
Click to expand...
The arrogance was enormous. We haven't launched anything well in decades and we thought we could do better. Otezla is almost entirely profit.

I don't like them, but awards all around to Celgene for being able to sell that thing to $2billion in 4 years. Amgen probably overpaid, given they killed the product's growth but we should have kept it and sold deucra off. We are pretty good at extracting profit from established products.

It is nice to see that Amgen sucks as well. They brought in their own stooges and killed it. Glad to see that lucky charm little bastard Murdo fail so hard. Remember when he left us? Remember when he told the Street AMGN could continue to grow Otezla double digits for a the reminder of the life cycle? Does he not know how corrupt and toxic his sales culture is over there?
 








Otezla is a placebo. Hats off to the bikini models that pushed it to 2 billion.

BUT, BUT, BUT, it should have nothing to do with our disaster. There is no excuse for us not doing better. Superior molecule. Superior efficacy, Superior AE profile, superior dosing and starting year 3 we are a complete failure. Why?

The reasons are many:

-poor leadershsip
-no understanding of derm offices
-reliance on 1990 speaker program tactics
-bad rep maps and alignments
-hired the wrong derm experience
-reliance on R&F model that doesn't work in derm
-terrible HUB
-terrible IC capture and worse IC plan
-unrealistic goal setting
-weak promotional pieces
 




anonymous said:
Otezla is a placebo. Hats off to the bikini models that pushed it to 2 billion.

BUT, BUT, BUT, it should have nothing to do with our disaster. There is no excuse for us not doing better. Superior molecule. Superior efficacy, Superior AE profile, superior dosing and starting year 3 we are a complete failure. Why?

The reasons are many:

-poor leadershsip
-no understanding of derm offices
-reliance on 1990 speaker program tactics
-bad rep maps and alignments
-hired the wrong derm experience
-reliance on R&F model that doesn't work in derm
-terrible HUB
-terrible IC capture and worse IC plan
-unrealistic goal setting
-weak promotional pieces
Click to expand...
You forgot not having the co-pay cards readily accessible for patients at the HUB level.
 




I've been in dermatology for 20+ years. Seen a lot come and go.

I've never seen anything like the first couple years of Otezla. Their sales force was a force to behold. Smoking hot. Got in everywhere, including most the no sees. Product was at best marginal and they created a buzz like I've never seen. No wonder they sold so much. After the first couple years, say 2016 or so, they all started marrying plastic surgeons and it changed, but whoever put that initial team together knew what they were doing.
 




anonymous said:
I've been in dermatology for 20+ years. Seen a lot come and go.

I've never seen anything like the first couple years of Otezla. Their sales force was a force to behold. Smoking hot. Got in everywhere, including most the no sees. Product was at best marginal and they created a buzz like I've never seen. No wonder they sold so much. After the first couple years, say 2016 or so, they all started marrying plastic surgeons and it changed, but whoever put that initial team together knew what they were doing.
Click to expand...
HIRING OF KARENS/KEVINS KILLED US!!
 




anonymous said:
HIRING OF KARENS/KEVINS KILLED US!!
Click to expand...
We went out and hired the WRONG dermatology experience.

On paper looked good. But dig a bit deeper and you know we hired people from PODS (no accountability) who sold preferred position products (no hustle needed).

We even hired people with known bat crazy backgrounds like Ralph and immediately promoted them to keep them away from direct reports.

We just didn't get the hiring profile right.

Rest is history.
 




anonymous said:
I've been in dermatology for 20+ years. Seen a lot come and go.

I've never seen anything like the first couple years of Otezla. Their sales force was a force to behold. Smoking hot. Got in everywhere, including most the no sees. Product was at best marginal and they created a buzz like I've never seen. No wonder they sold so much. After the first couple years, say 2016 or so, they all started marrying plastic surgeons and it changed, but whoever put that initial team together knew what they were doing.
Click to expand...
Not sure where you're located but the OTEZLA team where I am does not even come close to what you are describing.
 




anonymous said:
I've been in dermatology for 20+ years. Seen a lot come and go.

I've never seen anything like the first couple years of Otezla. Their sales force was a force to behold. Smoking hot. Got in everywhere, including most the no sees. Product was at best marginal and they created a buzz like I've never seen. No wonder they sold so much. After the first couple years, say 2016 or so, they all started marrying plastic surgeons and it changed, but whoever put that initial team together knew what they were doing.
Click to expand...
Several of those AMGEN reps that launched Otezla are here. Not a smoke show in sight. Just over filled faces with zero selling skills. Otezla took off because it was the first pill. The Otezla rep in my territory slept with numerous doctors to get her numbers. I know because several of the doctors flat out said it.
 




Top Bottom
Back
Quote